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pRevalenCe, natuRe, and Causes 
of pResCRIbIng eRRoRs In geneRal 
pRaCtICe
Over the past 10 years our team has been 
involved in a wide range of studies of 
prescribing in general practice, but one we 
feel that has really made a difference is the 
PRACtICe study, which was funded by the 
General Medical Council.1,2 In this study 
we took a sample of 15 general practices 
across England and did a retrospective 
review of the clinical records of a random 
sample of over 1700 patients, and over 
6000 prescription items. Using a definition 
of error that focused on clinically important 
problems,1 we found that one in 20 (5%) 
prescription items was associated with one 
or more prescribing or monitoring errors, 
and that one in 550 prescription items 
contained what we regarded as a severe 
error1 (with seriously inadequate monitoring 
of patients taking warfarin the biggest 
culprit). We found that per prescription 
item, errors were more common in 
children and older people, and that nearly 
half of patients receiving >10 items over 
the course of a year were the recipients 
of an error. The commonest types of error 
related to incomplete information on the 
prescription, dose-strength errors, and 
timing-frequency errors.
Using interviews, root cause analyses and 
focus groups, we explored the underlying 
causes of the errors and, not surprisingly, 
found them to be multifactorial.2 Of the 
various underlying causes, we felt that 
several were amenable to intervention, 
including improving safety systems in 
general practices; making best use of our 
electronic prescribing systems, including 
computerised clinical decision support; 
improving prescribing and monitoring 
at the interface between primary and 
secondary care, and better training for 
GPs in therapeutics and safe prescribing 
(accepting that most GPs already have 
good therapeutic knowledge and are highly 
committed to patient safety). We made 
a number of recommendations from our 
research and have taken several of these 
forward as described later in this article, 
and in Box 1.
pReventable dRug-Related 
hospItal admIssIons
Not all prescribing errors in general 
practice lead to patient harm, but some 
of the most serious errors are associated 
with preventable drug-related hospital 
admissions. In a study of over 4000 patients 
admitted to a large teaching hospital in 
Nottingham, UK, we found that 6.5% of 
these admissions were judged to be drug-
related and two-thirds to be preventable.3 
We did a systematic review of similar studies 
across the world which showed a median of 
3.7% (range 1.4–15.4) of admissions were 
drug-related and preventable.4 
As part of this study we also identified the 
types of drug most commonly associated 
with preventable hospital admissions. 
What is striking about these findings is 
that just four classes of drug (antiplatelet 
agents, diuretics, non-steroidal anti-
inflammatories, and anticoagulants) 
accounted for over 50% of preventable drug-
related admissions, and these, together 
with opioid analgesics, beta-blockers, drugs 
acting on the renin-angiotensin system, 
drugs used in diabetes, positive inotropes 
such as digoxin, and corticosteroids, 
accounted for 75% of these admissions. 
This provides useful information for GPs 
wanting to know which drugs they need to 
prescribe and monitor with particular care.
pResCRIbIng safety IndICatoRs
Our team has done a lot of work to identify 
prescribing safety indicators for use in 
general practice. These are scenarios 
which represent potentially unsafe (or 
inappropriate) prescribing, and examples 
are shown in Box 2. Their purpose is to 
improve safety by identifying patients at 
risk so that prescribing problems can be 
tackled before patients come to harm. 
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We have searched the literature for these 
prescribing safety indicators and used 
consensus building techniques with GPs 
to identify those considered appropriate for 
assessing the safety of prescribing in UK 
general practice. 
We have recently published our latest 
set of 54 prescribing safety indicators in the 
BJGP.5 Practices can use these indicators 
to identify patients at risk from prescribing; 
we have also used this approach in the 
PINCER trial.6
gp ComputeR systems
Clinical computer systems have 
considerable potential to improve the safety 
of prescribing7 and yet research we did 
around 10 years ago for the National Patient 
Safety Agency showed major deficiencies in 
the safety features of the most commonly–
used GP computer systems used at the 
time.8 We also showed that GP training was 
often inadequate in terms of learning about 
the safety features of clinical computer 
systems,9 and that GPs commonly admitted 
to overriding computerised alerts without 
properly checking them.10 This led us to 
work with the National Programme for IT in 
the NHS to identify evidence to support the 
use of computerised alerts and prompts to 
improve clinicians prescribing behaviour;7 
reach consensus on the most important 
safety features for GP computer systems,11 
and advise on the best ways of designing 
and implementing medication safety 
alerts in clinical information systems.12 We 
cannot be certain what impact this has had, 
but there have certainly been significant 
improvements in the safety features of 
GP computer systems in the past decade, 
with the leading systems taking note of 
suggestions made by ourselves and others. 
For example, as a result of the PRACtICe 
study, TPP SystmOne implemented a range 
of new safety features to take account of 
our recommendations, such as warnings 
for clinicians who issue a repeat medication 
without appropriate tests.13
ReduCIng pResCRIbIng eRRoRs: the 
pInCeR tRIal appRoaCh
On the basis of our earlier research, we 
developed a pharmacist-led IT-based 
intervention aimed at reducing prescribing 
errors in general practices and evaluated 
this in the PINCER trial.6 The study 
involved searching GP computer systems 
to identify patients at risk from specific 
prescribing problems; examples of these 
are shown in Box 1. Seventy-two general 
practices were recruited to the study and 
all received feedback on the patients at 
risk with suggestions of how to deal with 
the problems identified. In the pharmacist-
intervention arm of the trial, a pharmacist 
met with the practice and used educational 
outreach techniques to discuss the 
importance of the problems identified. The 
pharmacist then worked with the practice 
over a 12-week period to tackle the safety 
problems. The study showed that the 
pharmacist-led intervention was effective 
at reducing a range of medication errors 
at 6 and 12 months after the intervention, 
although the effects were less at 12 months. 
box 1. selected recommendations from gmC-funded pRaCtICe 
study, and actions taken 
Recommendation action taken
Review the RCGP curriculum to give greater  Revisions made to 2013 RCGP curriculum with 
prominence to therapeutic knowledge, and the  five new learning objectives added and revisions 
skills and attitudes needed for safe prescribing made to two existing learning objectives.
Develop an educational package highlighting key  Educational package entitled ‘Prescribing in 
learning points from the PRACtICe Study to  General Practice’ developed and launched on 
support reflection and, where appropriate, for use RCGP website January 2014:  
in identifying GPs’ personal development needs. http://elearning.rcgp.org.uk/
Develop an educational package to enable GPs  We are currently piloting and evaluating a 
in training to assess the safety of their prescribing  pharmacist-led initiative to provide educational 
(for example, by structured examination of, and  feedback on the prescribing of ‘100 prescriptions’ 
reflection on, a sample of their prescription items). for a sample of GPs in training.
Develop strategies for improving prescribing   With the NIHR Greater Manchester Primary Care 
safety systems in general practices. Patient Safety Translational Research Centre we  
 are investigating how prescribing safety systems  
 can be improved in general practices.
Help general practices to identify patients at risk  Prescribing safety indicators from the PINCER 
from prescribing errors by conducting audits  trial made available to general practices to 
using prescribing safety indicators;  correct  download and run on their GP computer systems: 
problems identified using evidence-based  http://www.nottingham.ac.uk/primis/tools/audits/ 
approaches (such as support from pharmacists, pincer.aspx 
as demonstrated in the PINCER trial6).  
Make improvements to the prescribing safety  The GP computer system, TPP SystmOne, 
features of GP computer systems. introduced a raft of changes in response to the  
 PRACtICe report.13
box 2. selection of prescribing safety indicators used in the  
pInCeR trial6
1. Patients with a history of peptic ulcer who have been prescribed a non-selective non-steroidal  
 anti-inflammatory drug without co-prescription of a proton-pump inhibitor. 
2. Patients with a history of asthma who have been prescribed a beta-blocker.
3. Patients aged ≥75 years who have been prescribed an angiotensin converting enzyme inhibitor or a loop  
 diuretic long term who have not had a computer-recorded check of their renal function and electrolytes  
 in the previous 15 months.
4. Women with a past medical history of venous or arterial thrombosis who have been prescribed combined  
 hormonal contraceptives. 
5. Patients receiving methotrexate for at least 3 months who have not had a recorded full blood count or  
 liver function test within the previous 3 months.
6. Patients receiving warfarin for at least 3 months who have not had a recorded check of their international  
 normalised ratio within the previous 12 weeks.
7. Patients receiving lithium for at least 3 months who have not had a recorded check of their lithium  
 concentrations in the previous 3 months.
8. Patients receiving amiodarone for at least 6 months who have not had a thyroid function test within the  
 previous 6 months.
Embedded qualitative work demonstrated 
that GPs and their teams trusted the 
pharmacists to be able to address the 
important prescribing and monitoring 
problems identified.14 Economic analysis 
has shown that the intervention is likely to 
be cost-effective.6,15
There has subsequently been a lot of 
interest from a range of organisations, 
including the English Department of Health, 
in rolling out the PINCER intervention. In 
response to this, we have made a selection 
of the computer queries used in the PINCER 
trial (Box 1) freely available to UK general 
practices. At the time of writing, 1271 GP 
practices across 173 clinical commissioning 
groups have downloaded these computer 
queries to identify patients at risk. The tool is 
available at: http://www.nottingham.ac.uk/
primis/tools/audits/pincer.aspx. In addition, 
the computer queries used in the PINCER 
trial have been incorporated into the clinical 
decision support software used in a number 
of GP clinical computer systems. We are 
currently conducting follow-on research to 
refine the PINCER intervention and further 
enhance its clinical and cost effectiveness.
ImpRovIng gp eduCatIon and 
tRaInIng In theRapeutICs and safe 
pResCRIbIng
One of the recommendations from our 
PRACtICe study1,2 was to identify ways of 
improving GP education and training in 
therapeutics and safe prescribing. We have 
subsequently worked closely with the Royal 
College of General Practitioners (RCGP) 
and the NIHR Greater Manchester Primary 
Care Patient Safety Translational Research 
Centre (GMPCPSTRC) to address this.
The most important thing we have 
done is to draw on all the work we have 
done to date in order to develop learning 
materials for GPs. We produced six articles 
which were published in the August 2013 
edition of InnovAiT, the RCGP journal for 
GPs in training. Subsequently, with support 
from the Medical Defence Union and 
NIHR GMPCPSTRC, we have developed 
e-learning materials on ‘prescribing in 
general practice’ which are hosted by the 
RCGP e-learning site: http://elearning.
rcgp.org.uk/. Five lessons are available, 
each emphasising a different aspect of 
safe prescribing. In the 6 weeks following 
the launch of the e-learning materials in 
January 2014, over 1200 GPs had accessed 
the course and the feedback so far has 
been very positive.
In addition, we have worked with the 
RCGP to make changes to the RCGP 
Curriculum in order to put greater emphasis 
on therapeutics and safe prescribing. These 
changes were introduced in August 2013. 
Furthermore, we have worked with MRCGP 
examiners to identify ways in which there 
might be greater emphasis on assessing 
therapeutic knowledge and prescribing 
skills, particularly in the Clinical Skills 
Assessment.
patIent safety toolKIt pRoJeCt
With funding from NIHR School for 
Primary Care Research we have done a 
systematic review to identify tools used for 
assessing patient safety in primary care. 
Using an international expert panel, and the 
knowledge and experience of our project 
team, we have identified and piloted those 
tools that we think are most suitable for 
use in UK general practice. We are about 
to roll these tools out in 50 practices across 
England and then hope to make tools more 
widely available to other practices in the UK.
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